These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31536894)

  • 1. Structure activity relationship towards design of cryptosporidium specific thymidylate synthase inhibitors.
    Czyzyk DJ; Valhondo M; Deiana L; Tirado-Rives J; Jorgensen WL; Anderson KS
    Eur J Med Chem; 2019 Dec; 183():111673. PubMed ID: 31536894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural studies provide clues for analog design of specific inhibitors of Cryptosporidium hominis thymidylate synthase-dihydrofolate reductase.
    Kumar VP; Cisneros JA; Frey KM; Castellanos-Gonzalez A; Wang Y; Gangjee A; White AC; Jorgensen WL; Anderson KS
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4158-61. PubMed ID: 25127103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substituted pyrrolo[2,3-d]pyrimidines as Cryptosporidium hominis thymidylate synthase inhibitors.
    Kumar VP; Frey KM; Wang Y; Jain HK; Gangjee A; Anderson KS
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5426-8. PubMed ID: 23927969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the structural basis of species selective, stereospecific inhibition for Cryptosporidium and human thymidylate synthase.
    Czyzyk DJ; Valhondo M; Jorgensen WL; Anderson KS
    FEBS Lett; 2019 Aug; 593(15):2069-2078. PubMed ID: 31172516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the TS dimer interface in bifunctional Cryptosporidium hominis TS-DHFR from parasitic protozoa: Virtual screening identifies novel TS allosteric inhibitors.
    Ruiz VG; Czyzyk DJ; Kumar VP; Jorgensen WL; Anderson KS
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127292. PubMed ID: 32631514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel allosteric covalent inhibitors of bifunctional Cryptosporidium hominis TS-DHFR from parasitic protozoa identified by virtual screening.
    Ruiz V; Czyzyk DJ; Valhondo M; Jorgensen WL; Anderson KS
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1413-1418. PubMed ID: 30929953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents.
    Gangjee A; Lin X; Kisliuk RL; McGuire JJ
    J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 2-amino-4-oxo-5-arylthio-substituted-pyrrolo[2,3-d]pyrimidines as nonclassical antifolate inhibitors of thymidylate synthase.
    Gangjee A; Jain HD; Kisliuk RL
    Bioorg Med Chem Lett; 2005 May; 15(9):2225-30. PubMed ID: 15837298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual inhibitors of thymidylate synthase and dihydrofolate reductase as antitumor agents: design, synthesis, and biological evaluation of classical and nonclassical pyrrolo[2,3-d]pyrimidine antifolates(1).
    Gangjee A; Jain HD; Phan J; Lin X; Song X; McGuire JJ; Kisliuk RL
    J Med Chem; 2006 Feb; 49(3):1055-65. PubMed ID: 16451071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of classical and nonclassical 2-amino-4-oxo-5-substituted-6-methylpyrrolo[3,2-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors.
    Gangjee A; Li W; Yang J; Kisliuk RL
    J Med Chem; 2008 Jan; 51(1):68-76. PubMed ID: 18072727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nanotherapy strategy significantly enhances anticryptosporidial activity of an inhibitor of bifunctional thymidylate synthase-dihydrofolate reductase from Cryptosporidium.
    Mukerjee A; Iyidogan P; Castellanos-Gonzalez A; Cisneros JA; Czyzyk D; Ranjan AP; Jorgensen WL; White AC; Vishwanatha JK; Anderson KS
    Bioorg Med Chem Lett; 2015; 25(10):2065-7. PubMed ID: 25900220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, antifolate, and antitumor activities of classical and nonclassical 2-amino-4-oxo-5-substituted-pyrrolo[2,3-d]pyrimidines.
    Gangjee A; Vidwans A; Elzein E; McGuire JJ; Queener SF; Kisliuk RL
    J Med Chem; 2001 Jun; 44(12):1993-2003. PubMed ID: 11384244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two crystal structures of dihydrofolate reductase-thymidylate synthase from Cryptosporidium hominis reveal protein-ligand interactions including a structural basis for observed antifolate resistance.
    Anderson AC
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Mar; 61(Pt 3):258-62. PubMed ID: 16511011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Explaining an unusually fast parasitic enzyme: folate tail-binding residues dictate substrate positioning and catalysis in Cryptosporidium hominis thymidylate synthase.
    Martucci WE; Vargo MA; Anderson KS
    Biochemistry; 2008 Aug; 47(34):8902-11. PubMed ID: 18672899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of 6-substituted pyrrolo[2,3-d]pyrimidines as dual inhibitors of TS and AICARFTase and as potential antitumor agents.
    Liu Y; Li M; Zhang H; Yuan J; Zhang C; Zhang K; Guo H; Zhao L; Du Y; Wang L; Ren L
    Eur J Med Chem; 2016 Jun; 115():245-56. PubMed ID: 27017552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel non-active site inhibitor of Cryptosporidium hominis TS-DHFR identified by a virtual screen.
    Martucci WE; Udier-Blagovic M; Atreya C; Babatunde O; Vargo MA; Jorgensen WL; Anderson KS
    Bioorg Med Chem Lett; 2009 Jan; 19(2):418-23. PubMed ID: 19059777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonconserved residues Ala287 and Ser290 of the Cryptosporidium hominis thymidylate synthase domain facilitate its rapid rate of catalysis.
    Doan LT; Martucci WE; Vargo MA; Atreya CE; Anderson KS
    Biochemistry; 2007 Jul; 46(28):8379-91. PubMed ID: 17580969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidines as potential nonclassical antifolates targeting both thymidylate and purine nucleotide biosynthesis.
    Liu Y; Zhang C; Zhang H; Li M; Yuan J; Zhang Y; Zhou J; Guo H; Zhao L; Du Y; Wang L; Ren L
    Eur J Med Chem; 2015 Mar; 93():142-55. PubMed ID: 25668494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the crossover helix impairs dihydrofolate reductase activity in the bifunctional enzyme TS-DHFR from Cryptosporidium hominis.
    Vargo MA; Martucci WE; Anderson KS
    Biochem J; 2009 Feb; 417(3):757-64. PubMed ID: 18851711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The crystal structure of thymidylate synthase from Pneumocystis carinii reveals a fungal insert important for drug design.
    Anderson AC; Perry KM; Freymann DM; Stroud RM
    J Mol Biol; 2000 Mar; 297(3):645-57. PubMed ID: 10731418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.